Trends in Biotechnology�is unique in drawing together a wide readership of scientists and engineers from the many disciplines of the applied biosciences. As in the successful biotechnology companies and leading academic research groups,�Trends in Biotechnology�reflects the view that biotechnology is the integrated use of many biological technologies - from plant genetics to biomedical engineering. This integration is essential for the effective translation of novel research into application. The journal addresses what is new, significant and practicable.
Its successful blend of articles has made�Trends in Biotechnology�one of the most highly regarded and highly cited review journals in the field.
Elsevier�(Dutch pronunciation:�['?lz?vir]) is a�publishing company�which publishes medical and scientific literature. It is a part of the�Reed Elsevier�group. Based in�Amsterdam, the company has operations in the United Kingdom, USA and elsewhere.Elsevier took its name from the�Dutch publishing house, which, however, had no connection with the present company. The Elzevir family operated as booksellers and publishers in the�Netherlands. Its founder,�Lodewijk Elzevir, (1542�1617) lived in�Leiden�and established the business in 1580.